Real‐world outcomes of patients with resected stage III melanoma treated with adjuvant therapies

Documenti analoghi

• Genetic Landscape of Mucosal Melanoma: Identifying Pathogenic Germline Variants
  di: Isabella Ribaudo, et al.
  Pubblicazione: (2025)
• Real‐world experience of adjuvant immunotherapy for stages III–IV melanoma: A monocentric observational study
  di: Manon Blaise, et al.
  Pubblicazione: (2025)
• Comment on ‘adjuvant anti‐PD‐1 antibody versus observation for resected nail apparatus melanoma’
  di: Junhua Qi, et al.
  Pubblicazione: (2026)
• Real‐world outcomes of adjuvant therapies in stage III / IV melanoma: Insights from the French RIC ‐ MEL cohort
  di: M. Vuillemey, et al.
  Pubblicazione: (2025)
• A Systematic Review of Disparities in Alzheimer's Diagnosis: The Overlooked Impact of Gender and Ethnoracial Diversity on Biomarker Expression
  di: Cynthia Isabel Smith, et al.
  Pubblicazione: (2025)